FDA Appoints Acting Heads of Drug and Vaccine Centers to Permanent Positions
Source Summary
The FDA has named acting heads of its drug and vaccine centers to permanent roles, bringing stability to the agency following recent departures of senior leadership. The moves address turnover at the top levels of the regulatory body responsible for drug and vaccine oversight.
Why it matters
Leadership continuity at the FDA's drug and vaccine centers is critical for maintaining regulatory oversight and public confidence in pharmaceutical and vaccine approval processes.
